Trials / Conditions / Neoadjuvant Treatment

Neoadjuvant Treatment

14 registered clinical trials studyying Neoadjuvant Treatment — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery NCT06959511	M.D. Anderson Cancer Center	Phase 2
Recruiting	Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Ex NCT06928701	University of Eastern Piedmont	N/A
Recruiting	Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carci NCT06576973	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 2
Withdrawn	Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer NCT04620473	Shanghai Minimally Invasive Surgery Center	Phase 2
Active Not Recruiting	Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer NCT05524012	Jena University Hospital	—
Unknown	Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy NCT05111860	Shanghai Minimally Invasive Surgery Center	Phase 1 / Phase 2
Active Not Recruiting	Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment NCT05382052	Fundación GECP	—
Recruiting	The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advan NCT05343325	Fifth Affiliated Hospital, Sun Yat-Sen University	Phase 2
Unknown	Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy NCT04923620	Shanghai Minimally Invasive Surgery Center	—
Unknown	Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma NCT04622566	Peking University Cancer Hospital & Institute	Phase 2
Recruiting	Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma NCT04280822	Henan Cancer Hospital	Phase 3
Unknown	Adaptive Individualized High-Dose Radiotherapy Analysis-REctum-1 (AIDA-RE-1) NCT03479814	IRCCS Azienda Ospedaliero-Universitaria di Bologna	N/A
Unknown	A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cance NCT02489006	University Health Network, Toronto	Phase 2
Unknown	Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer NCT00506844	National Cancer Center, Korea	Phase 2